by jlohrconsulting | Oct 6, 2025 | Uncategorized
Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(9):28-36. doi: 10.17116/jnevro202512509128. ABSTRACT Semaglutide is a glucagon-like peptide-1 receptor agonist, approved and currently actively used worldwide for the treatment of type 2 diabetes mellitus and obesity....
by jlohrconsulting | Oct 6, 2025 | Uncategorized
Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(9):37-41. doi: 10.17116/jnevro202512509137. ABSTRACT Cervical dystonia (CD) is an urgent problem in neurology and healthcare in general. One of the CD manifestations is head tremor, which affects up to 60% of patients....
by jlohrconsulting | Oct 6, 2025 | Uncategorized
Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(9):71-78. doi: 10.17116/jnevro202512509171. ABSTRACT OBJECTIVE: To study clinical features of hysterical disorders in patients with hematological diseases. MATERIAL AND METHODS: A prospective study of patients with...
by jlohrconsulting | Oct 6, 2025 | Uncategorized
Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(9):79-89. doi: 10.17116/jnevro202512509179. ABSTRACT OBJECTIVE: To study the effect of magnetic resonance imaging-guided focused ultrasound (MR-FUS) on the motor and non-motor symptoms of essential tremor (ET) (cognitive...
by jlohrconsulting | Oct 6, 2025 | Uncategorized
Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(9):90-98. doi: 10.17116/jnevro202512509190. ABSTRACT OBJECTIVE: To study the antidepressant efficacy and the tolerability of agomelatine (Valdoxan) in daily clinical practice in patients with a depressive episode that...
Recent Comments